LOI Submission Deadline: July 14, 2016
This year, Susan G. Komen is offering grant funding mechanisms for which early career breast cancer researchers anywhere in the world are invited to apply. These three Komen Training and Career Development awards seek to bridge the funding gap faced by recently graduated Ph.D.s and early faculty as they start their careers in breast cancer research. Grants funded by Komen provide the preparation necessary to compete for independent funding as an established and successful breast cancer researcher.
Career Catalyst Research Grants
Career Catalyst (CCR) Grants are intended to foster promising breast cancer researchers who are in the early stages of their faculty careers by providing support for up to three years of “protected time” for research career development under the guidance of a Mentor Committee. It is expected that awardees will launch independent research careers and successfully compete for subsequent research project funding in breast cancer following the successful completion of a CCR Grant, thereby playing key roles in reducing breast cancer incidence and mortality within the next decade, with the ultimate goal of ending breast cancer forever.
The Letter of Intent must propose hypothesis-driven research that directly relates to breast cancer and clearly describes the significant potential to lead to reductions in breast cancer incidence and/or mortality within the next decade. Research that does not directly relate to breast cancer will be administratively withdrawn from consideration and will not be reviewed or scored.
Value: Applicants can request funding of up to $150,000 (USD)/year for up to 3 years.
Post-Doctoral Fellowship Grants
PDF Grants are intended to attract and preserve today’s young scientists and clinicians who will fuel the future and become the next generation of leaders in the field of breast cancer research. These leaders will play key roles in reducing breast cancer incidence and mortality within the next decade, with the ultimate goal of ending breast cancer forever.
Value: Up to $180,000 direct costs only; ($60,000 per year for 2 to 3 years)